iopanoic acid
Trade name: telepaque
Small moleculeapproved
Approved
Jul 16, 1951
Iopanoic acid is a representative iodinated ionic monomeric contrast medium. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1950s
- Jul 16, 1951
General Electric — Earliest FDA Approval
- Jul 16, 1951
General Electric — NDA Secondary Org
- Jul 16, 1951
General Electric — NDA Organization
Indications
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedPriority reviewJul 16, 1951
Chemistry & pharmacology
Loading structure…
SMILES
CCC(CC1=C(I)C=C(I)C(N)=C1I)C(O)=O- Mol. weight
- 570.9319 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIopanoic acid ↗
- NCATSFE9794P71J ↗
- ChEMBLCHEMBL867 ↗
- ChEMBLCHEMBL2104291 ↗
Also known as
- acidum iopanoicum
- acidum iopanoicum
- iodopanic acid
- iodopanoic acid
- iodopanoic acid
- iodopanoic acid
- iodopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoic acid
- iopanoicum
- jopanoic acid
- jopanoic acid
- telapaque
- telepaque
- telepaque
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| General Electric | For profit | NDA2 | Jul 16, 1951 |
| General Electric | For profit | NDA | Jul 16, 1951 |